abstract |
Disclosed are methods and compositions for the treatment of fibrotic diseases. More specifically, the present invention demonstrates that inhibiting or otherwise reducing activity of CCL21 alone or in combination with CCL19 is effective in reducing the presence of fibrotic lesions and improving the syndrome of fibrotic disorders. |